| Drug General Information |
| Drug ID |
D0NV9C
|
| Former ID |
DNC010717
|
| Drug Name |
2-(4-bromophenylsulfonamido)-N-hydroxyacetamide
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C8H9BrN2O4S
|
| Canonical SMILES |
C1=CC(=CC=C1S(=O)(=O)NCC(=O)NO)Br
|
| InChI |
1S/C8H9BrN2O4S/c9-6-1-3-7(4-2-6)16(14,15)10-5-8(12)11-13/h1-4,10,13H,5H2,(H,11,12)
|
| InChIKey |
AKOBMMAQXVKOJR-UHFFFAOYSA-N
|
| PubChem Compound ID |
|
| Target and Pathway |
| Target(s) |
ADAM 17 |
Target Info |
Inhibitor |
[1]
|
|---|
| Matrix metalloproteinase-14 |
Target Info |
Inhibitor |
[1]
|
|
KEGG Pathway
|
Notch signaling pathway
|
|
Alzheimer's disease
|
|
Epithelial cell signaling in Helicobacter pylori infectionhsa04668:TNF signaling pathway
|
|
GnRH signaling pathway
|
|
PANTHER Pathway
|
Alzheimer disease-amyloid secretase pathway
|
|
Alzheimer disease-presenilin pathway
|
|
Notch signaling pathwayP00004:Alzheimer disease-presenilin pathway
|
|
Pathway Interaction Database
|
ErbB4 signaling events
|
|
TNF receptor signaling pathway
|
|
p75(NTR)-mediated signalinghif2pathway:HIF-2-alpha transcription factor network
|
|
Signaling events mediated by focal adhesion kinase
|
|
Reactome
|
Nuclear signaling by ERBB4
|
|
Collagen degradation
|
|
Regulated proteolysis of p75NTR
|
|
Activated NOTCH1 Transmits Signal to the Nucleus
|
|
Constitutive Signaling by NOTCH1 PEST Domain Mutants
|
|
Constitutive Signaling by NOTCH1 t(7
|
|
M1580_K2555) Translocation Mutant
|
|
Constitutive Signaling by NOTCH1 HD Domain Mutants
|
|
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
|
|
TNF signaling
|
|
Growth hormone receptor signalingR-HSA-1442490:Collagen degradation
|
|
Degradation of the extracellular matrix
|
|
Activation of Matrix Metalloproteinases
|
|
WikiPathways
|
Notch Signaling Pathway
|
|
Copper homeostasis
|
|
Notch Signaling Pathway
|
|
Growth hormone receptor signaling
|
|
BDNF signaling pathway
|
|
Alzheimers Disease
|
|
Signalling by NGF
|
|
Extrinsic Pathway for ApoptosisWP615:Senescence and Autophagy in Cancer
|
|
Activation of Matrix Metalloproteinases
|
|
Degradation of collagen
|
|
AGE/RAGE pathway
|
|
Matrix Metalloproteinases
|
| References |
| REF 1 | J Med Chem. 2010 Mar 25;53(6):2622-35.Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models. |
|---|
